Drugs / 1RG-CART
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02761915 | Feb 2016 → Dec 2020 | — | Cancer Research UK | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1RG-CART | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02761915 ↗ |
| Modality | Cell therapy | “patients have their T-cells (a type of white blood cell) collected and modified in the laboratory, before they are given back to the patient” NCT02761915 ↗ |
| Route | Intravenous | “1RG-CART will be administered intravenously.” NCT02761915 ↗ |